# Avalo Therapeutics, Inc. — Form D

Avalo Therapeutics, Inc. of ROCKVILLE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2012-04-04. The offering totals $22.5M, of which $22.1M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2012-04-04
- Form: D
- Accession: 0001534120-12-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $22.5M
- Amount sold: $22.1M
- Remaining: $363K
- Minimum investment: $24K
- Investors: 156
- Date of first sale: 2012-03-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-176170

## Issuer

- Name: Avalo Therapeutics, Inc.
- CIK: 0001534120
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 540 GAITHER ROAD, ROCKVILLE, MD, 20850
- Phone: 410-522-8707

## Officers, directors & promoters (52)

_Showing 25 of 52 people._

| Name | Role | Location |
| --- | --- | --- |
| Sol M Barer | Director | Baltimore, MD |
| Eugene M Bauer | Director | Baltimore, MD |
| Isaac M Blech | Director | Charlotte, NC |
| John M Catsimatidis | Director | Baltimore, MD |
| Cary M Sucoff | Director | Baltimore, MD |
| Karen M Krumeich | Executive Officer | Baltimore, MD |
| Reza M Mazhari | Executive Officer | Baltimore, MD |
| Sharon M Rowland | Executive Officer | Baltimore, MD |
| John Kaiser | Executive Officer | Research Triangle Park, NC |
| Behshad Sheldon | Director | Malvern, PA |
| CHRISTOPHER SULLIVAN | Executive Officer | New York, NY |
| Eugene Bauer | Director | Redwood City, CA |
| Magnus Persson | Director | Beachwood, OH |
| June Almenoff, M.D., Ph.D. | Director | Rockville, MD |
| Mitchell Chan | Director | Rockville, MD |
| Jonathan Goldman, M.D. | Director | Rockville, MD |
| Aaron Kantoff | Director | Rockville, MD |
| Gilla Kaplan, Ph.D. | Director | Rockville, MD |
| Magnus Persson, M.D., Ph.D. | Director | Rockville, MD |
| Samantha Truex | Director | Rockville, MD |
| Garry Neil, M.D. | Director | Rockville, MD |
| Garry Neil, M.D. | Executive Officer | Rockville, MD |
| Thomas Aasen | Director | Research Triangle Park, NC |
| Uli Hacksell | Director | WAKE FOREST, NC |
| Uli Hacksell | Executive Officer | WAKE FOREST, NC |

## Other filings by this issuer (5)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-04-09](https://search.stillhousedata.com/formd/0001578563-24-000186) | D | $200.0M | $130.6M |
| [2017-05-08](https://search.stillhousedata.com/formd/0001534120-17-000001) | D | $5.0M | $5.0M |
| [2016-09-16](https://search.stillhousedata.com/formd/0001534120-16-000001) | D | $15.0M | $1.0M |
| [2014-07-21](https://search.stillhousedata.com/formd/0001534120-14-000002) | D | $33.3M | $16.3M |
| [2013-09-06](https://search.stillhousedata.com/formd/0001534120-13-000002) | D | $10.0M | $6.8M |

## More

- [CIK 1534120 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1534120&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001534120-12-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.